Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/133749
DC Field | Value | |
---|---|---|
dc.title | Treatment of choriocarcinoma in Singapore | |
dc.contributor.author | Chew, S.C. | |
dc.contributor.author | Ratnam, S.S. | |
dc.date.accessioned | 2016-12-20T08:39:37Z | |
dc.date.available | 2016-12-20T08:39:37Z | |
dc.date.issued | 1976 | |
dc.identifier.citation | Chew, S.C., Ratnam, S.S. (1976). Treatment of choriocarcinoma in Singapore. International Journal of Gynecology and Obstetrics 14 (2) : 173-176. ScholarBank@NUS Repository. | |
dc.identifier.issn | 00207292 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/133749 | |
dc.description.abstract | Over 750 cases of trophoblastic disease have been documented during the last 16 years. Of these, the majority were benign hydatidiform moles, but 106 patients had trophoblastic disease of a malignant nature. Those that were destructive or 'metastasizing moles' or frank choriocarcinoma were subdivided on histology into 'villous' or 'avillous' categories respectively. Where there was a persistence of HCG activity beyond the expected time after evacuation, or where there were secondaries on which no histology was available, they were classed as 'clinical choriocarcinoma'. The response of each of the tumours according to the above classification is presented in this paper and the difference in prognosis with the advent of drugs like methotrexate and others is discussed. | |
dc.type | Article | |
dc.contributor.department | OBSTETRICS & GYNAECOLOGY | |
dc.description.sourcetitle | International Journal of Gynecology and Obstetrics | |
dc.description.volume | 14 | |
dc.description.issue | 2 | |
dc.description.page | 173-176 | |
dc.description.coden | IJGOA | |
dc.identifier.isiut | NOT_IN_WOS | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.